The company in question is, ABIOMED, Inc. (NASDAQ:ABMD) currently with a stock price of 127.12 (-0.46% today). The market cap for ABIOMED, Inc. is 5496.64, and is in the sector Healthcare, and Medical Appliances & Equipment industry. The target price for ABIOMED, Inc. is 128.14. Currently ABIOMED, Inc. is trading with a P/E of 135.72, and a forward P/E of 70.99. Average volume for ABIOMED, Inc. is 403.49 and so far today it is 78326.
Performance in the last year for ABIOMED, Inc. has been 49.21%. For EPS growth, ABIOMED, Inc. has seen a growth of -68.00%, and is looking to grow in the next year to 53.37%. More long term stats show that EPS growth has been 36.20% over the last five years and could be 27.50% for the next five years. ABIOMED, Inc. has seen sales growth quarter over quarter at 40.30%, with EPS growth quarter over quarter at 45.40%. The 20-day simple moving average is 3.26%, with the 200-day simple moving average coming to 23.90%.
Since the IPO date for ABIOMED, Inc. on the 7/30/1987, ABIOMED, Inc. has seen performance year to date to be 41.46%. With ABIOMED, Inc. trading at 127.12, the dividend yield is *TBA, and the EPS is 0.94.
So could ABIOMED, Inc., be undervalued? Well as said before P/E is 135.72. The PEG is 4.94, P/S is 15.31 and the P/B is at 14.5. The P/cash is 24.63, with P/free cash flow at 74.89.
ABIOMED, Inc. ability to deal with debt shows that the current ratio is 6.9, and the quick ratio is 6.3. This is with long term debt/equity at 0, and total debt/equity at 0.
In terms of margins, ABIOMED, Inc. has a gross margin of 84.80%, an operating margin of 19.90% and a profit margin of 11.80%.Payout ratio for ABIOMED, Inc. is 0.00%. Return on assets come to 10.40% with return on investment coming to 10.10%.
Insider ownership for ABIOMED, Inc., is at 2.60% and institutional ownership comes to 95.00%. Outstanding shares are at 43.04. While shares float is 41.54. The float short is currently 4.37%, and short ratio is 4.5.